London · Delayed Price · Currency is GBP · Price in GBX Rentokil Initial Earnings Call Transcripts
Fiscal Year 2026
-
Q1 revenue grew 3.4% organically to $1.7B, led by North America and solid international gains. Business Services saw exceptional growth, though not expected to persist, while pricing remains the main driver amid stable retention and minimal impact from fuel or supply chain risks.
Fiscal Year 2025
-
Revenue grew 3.8% to $6.9B with strong H2 momentum, adjusted operating profit up 5.4%, and free cash flow conversion at 98%. North America and international segments both improved, with ongoing cost efficiencies and AI adoption supporting future growth.
-
Q3 revenue grew 4.6% year-over-year to $1.8 billion, with organic growth of 3.4% and improved North America performance. Customer and colleague retention rates rose, satellite branch rollout progressed, and cost efficiency initiatives remain on track. Full-year results are expected to meet market expectations.
-
Revenue grew 3.1% to $3.36B with strong cash conversion and solid international growth, though North America margins declined due to cost inflation and lower volumes. The France Workwear sale and cost efficiency programs support a positive outlook, with full-year guidance unchanged.
-
Revenue grew 1.5% in Q1 2025, with international markets outperforming North America. Strategic initiatives like new satellite branches and a door-to-door pilot aim to boost organic growth, while paid lead generation has improved but organic leads remain a focus.
Fiscal Year 2024
-
Revenue grew 3.9% to £5.6bn in 2024, with strong international growth offsetting North America underperformance. Integration of Terminix advanced, margins declined, and focus shifts to lead generation, sales execution, and leveraging both power and regional brands for future growth.
-
Q3 saw 3.6% revenue growth, with strong international performance but North America lagging, prompting cost cuts and operational changes. Integration and new growth initiatives are underway, with no change to 2024 guidance and synergy targets, though some timing may shift.
-
Q3 saw 3.6% total revenue growth, with strong international performance and modest North American gains. Cost-saving actions, integration progress, and customer retention initiatives are underway, while 2025 synergy realization is delayed by 2–3 months pending a Q1 review.
-
Full-year profit and margin guidance have been lowered due to underperformance and cost overruns in North America, with organic growth lagging the market. Integration and cost actions are progressing, cash conversion guidance is unchanged, and customer retention remains a key focus.
-
Full-year profit and margin guidance have been lowered due to weaker North American performance, cost overruns, and currency headwinds. Execution issues, not market weakness, are cited as the main challenge, with actions underway to improve lead flow, sales conversion, and retention. Integration and medium-term targets remain on track.
-
Revenue grew 4% to £2.8bn with all regions contributing, and adjusted operating profit rose 4.7% to £455m. North America showed early signs of recovery, with increased investment and successful integration of Terminix, while group margin and cash flow remained strong.